MedTrace Logo

FSH Followed by HMG vs FSH Plus HMG in IVF

NCT04385342 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 530

Last updated 2020-06-09

No results posted yet for this study

Summary

The aim of this study is to compare the clinical outcomes of sequential administration of FSH and HP-hMG FSH alone versus concomitant administration of FSH and HP-hMG during controlled ovarian stimulation in IVF cycles.

Conditions

  • IVF

Interventions

DRUG

FSH

Controlled ovarian stimulation by FSH followed by HMG versus FSH plus HMG

DRUG

HP-hMG

Controlled ovarian stimulation by FSH followed by HMG versus FSH plus HMG

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Ahmed Gibreel, MD · Mansoura University

  • Mohamed S Abdelhafez, MD · Mansoura University

  • Hasan El Maghraby, MD · Alexandria University

  • Hamed Yossef, MD · Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
37 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-30
Primary Completion
2022-05-30
Completion
2022-08-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04385342 on ClinicalTrials.gov